reference/1280309

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1280309

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	1198
issn	2095-8099
issueIdentifier	10
pageRange	1192-1198
publicationName	Engineering (Beijing, China)
startingPage	1192
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_95b2e699a9c607d2a787b9e3f026c793 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0124712e935bdbd9f0f57a120f0f9b0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7fddba722953073048af62e8d6f67804 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_89bacf767de58ae52d0b3ab5e8341b61 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_72820be1c4793c8fc861bd95b385285e
bibliographicCitation	Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X, Gu Y, Cai Q, Yang Y, Shen C, Li X, Peng L, Huang D, Zhang J, Zhang S, Wang F, Liu J, Chen L, Chen S, Wang Z, Zhang Z, Cao R, Zhong W, Liu Y, Liu L. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 Oct;6(10):1192–8. PMID: 32346491; PMCID: PMC7185795.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b132d8b27f37c47309ec8c7aa357c79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee605254b6a3197c6ffda9491ec08634 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4df766d5e0fc161b89efaa80d087d80c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c6cfd2d7411cb5e5ed017eab40f2786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98ecdf5b2fa3907e2eb09bb40b1b6a75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79845b9257a7e14a0537abfae18d0e38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7dcad0a4dd2c901376d32d4ea41f7f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6831adf2a640bd91a0e2c47c596c337f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2badfa5c597d217cfadea5624ad45c36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61d0531d8994f9e78edef7240fbd1d7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_776b94d840e8850bc847a0c2270c7cec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22e4502e31dca5f86087169ec34fee2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c807149b8113def17248d02a7545361 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71980fe3da7017ddab881a073a88d0e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d50641c0a2a14eae675650162de2c392 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8021-2537 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faf4c2c3990756b934d9098c2c8e0bdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa1ed555b12046ba2b0913aee235b0f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37e14f17fef3a299dccb563df52a8cb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bff26562c3aa0033e9881271989ddc9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_254e7b4c50c8b76036fb8a9da1950fcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b9711a9b2135bfa9b286c3adb4c9e1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08d239e92f1e8c18c3f9b13284a33407 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9feb86c15e82c333984986cdc1ec0a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_075e2207241c3537bf74113985f788fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32235105518c2477b48c01a813cbc290
date	202010
identifier	https://pubmed.ncbi.nlm.nih.gov/32346491 https://pubmed.ncbi.nlm.nih.gov/PMC7185795 https://doi.org/10.1016/j.eng.2020.03.007
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44680 https://portal.issn.org/resource/ISSN/2095-8099
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID492405 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9077 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9082 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_850d3dd3f0465864f03b25f855d284d1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406166238

Total number of triples: 60.